Photo by nci from unsplash
Essentials Anticoagulants prevent venous thromboembolism but may be associated with greater bleeding risks. Bivariate analysis assumes a non‐linear relationship between efficacy and safety outcomes. Extended full‐dose betrixaban is favorable over… Click to show full abstract
Essentials Anticoagulants prevent venous thromboembolism but may be associated with greater bleeding risks. Bivariate analysis assumes a non‐linear relationship between efficacy and safety outcomes. Extended full‐dose betrixaban is favorable over standard enoxaparin in bivariate endpoint. Clinicians must weigh efficacy and safety outcomes in decision‐making on thromboprophylaxis.
Keywords:
venous thromboembolism;
extended duration;
bivariate analysis;
effect extended
Journal Title: Journal of Thrombosis and Haemostasis
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Thrombosis and Haemostasis
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!